EUVIMEDObjevte EUVIMED
Open access · CC BY 4.0

Ellagic Acid‐Loaded sEVs Encapsulated in GelMA Hydrogel Accelerate Diabetic Wound Healing by Activating EGFR on Skin Repair Cells

Ellagsäure-beladene sEVs, in GelMA-Hydrogel verkapselt, beschleunigen die Heilung diabetischer Wunden durch Aktivierung von EGFR auf Hautreparaturzellen

Lige Tian, Zihao Wang, Shengqiu Chen, Kailu Guo, Yaying Hao, Liqian Ma, Kui Ma, Junli Chen, Xi Liu iD, Linlin Li, Xiaobing Fu, Cuiping Zhang iD

Cell Proliferation · 2025-10 · 58 (10)

DOI: 10.1111/cpr.70064 ↗

Auf einen Blick

In Zell- und Tiermodellen förderten ellagsäure-beladene sEVs die Wundheilung bei Diabetes. Der Effekt war mit verbesserter Funktion von Fibroblasten und Keratinozyten verbunden.

Fragestellung

Welche therapeutische Wirkung haben ellagsäure-verkapselte sEVs bei diabetischer Wundheilung, und über welchen Mechanismus wirken sie?

Methode

In-vitro- und In-vivo-Studie mit EA-sEVs aus CP-MSCs; Tests an HDFs und HEKs unter High Glucose sowie diabetische Wunden nach GelMA-Einbettung.

Ergebnisse

EA-sEVs förderten in vitro Proliferation, Migration und Transdifferenzierung von HG-HDFs sowie Proliferation und Migration von HG-HEKs. In vivo verbesserten Gel-EA-sEVs Re-Epithelisierung, Kollagenbildung und EGFR-Expression.

Schlussfolgerung der Autor:innen

Gel-EA-sEVs förderten die Heilung diabetischer Wunden durch Verbesserung biologischer Funktionen von HDFs und HEKs; EGFR war der spezifische Zielmechanismus von EA. Sie könnten als aktive Wundauflage dienen.

Kernaussagen

  • EA-sEVs verbesserten die Funktion von HDFs und HEKs unter High Glucose.
  • Gel-EA-sEVs beschleunigten die Heilung diabetischer Wunden im Tiermodell.
  • EGFR wurde als spezifisches biologisches Ziel von EA identifiziert.

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

At a glance

Journal article in Cell Proliferation, published online on 2025-05-19. Written by Lige Tian and 11 co-authors. Institution: College of Graduate, Tianjin Medical University, Tianjin, China. Major MEDLINE topics: Wound Healing, Ellagic Acid, Hydrogels, Diabetes Mellitus, Experimental. Cited 23 times so far (Crossref); 70 references. The full text is freely available (open access, CC BY 4.0). Funded by: Natural Science Foundation of Beijing Municipality, National Key Research and Development Program of China, National Natural Science Foundation of China.

Auf einen BlickAbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Delayed diabetic wound healing is partially attributed to the functional disorder of skin repair cells caused by high glucose (HG). Small extracellular vehicles (sEVs) loaded with small‐molecule drugs represent a highly promising therapeutic strategy. This study aims to evaluate the therapeutic efficacy of ellagic acid‐encapsulated small extracellular vesicles (EA‐sEVs) in diabetic wound regeneration and to unravel related mechanisms. Cytotoxicity tests of ellagic acid (EA) as liposomal small molecules (LSMs) were performed with the CCK8 assay. EA was incorporated into sEVs obtained from chorionic plate‐mesenchymal stem cells (CP‐MSCs) to construct EA‐engineered sEVs. The protective effects of EA‐sEVs on human dermal fibroblasts (HDFs) and human epidermal keratinocytes (HEKs) induced by high glucose (HG) were assessed through the evaluation of their proliferative, migrative and differentiative capabilities. Furthermore, to illustrate the underlying mechanism, the specific biological targets of EA were predicted and confirmed. Finally, EA‐sEVs were encapsulated in GelMA hydrogel for investigating the pro‐healing effects on diabetic wounds. EA was harmless to cell viability, increasing the possibility and safety of drug development. EA‐engineered sEVs were fabricated by loading EA in sEVs. In vitro, EA‐sEVs promoted the proliferation, migration, and transdifferentiation of HG‐HDFs and the proliferation and migration of HG‐HEKs. Mechanism analysis elucidated that epidermal growth factor receptor (EGFR) was the specific biological target of EA. EA interacting with EGFR was responsible for the functional improvement of HG‐HDFs and HG‐HEKs. In vivo, EA‐sEVs encapsulated in GelMA promoted the healing of diabetic wounds by improving re‐epithelialisation, collagen formation and the expression of EGFR. Gel‐EA‐sEVs promoted diabetic wound healing by improving biological functions of HDFs and HEKs. EGFR was first identified as the specific biological target of EA and was responsible for the functional improvement of HG‐HDFs and HG‐HEKs by Gel‐EA‐sEVs. Hence, Gel‐EA‐sEVs can serve as a new promising active dressing for diabetic wound treatment.

Subjects

MeSH terms (MEDLINE)

Wound HealingEllagic AcidHydrogelsDiabetes Mellitus, ExperimentalSkinErbB ReceptorsHumansAnimalsFibroblastsKeratinocytesCell ProliferationMiceCell MovementMesenchymal Stem CellsMale

Author keywords

GelMA hydrogeldiabetic wound healingellagic acidfibroblastskeratinocytessmall extracellular vesicles

Substances

ErbB ReceptorsEllagic AcidHydrogelsEGFR protein, human

Authors and institutions

  • College of Graduate, Tianjin Medical University, Tianjin, China.
  • Medical Innovation Research Department, PLA General Hospital, Beijing, China.
  • Chinese PLA Medical School, Beijing, China.
  • Innovation Research Center for Diabetic Foot, West China Hospital, Sichuan University, Chengdu, China.
  • PLA Key Laboratory of Tissue Repair and Regenerative Medicine, Beijing, China.
  • Beijing Key Laboratory of Micro-Nano Energy and Sensor, Center for High-Entropy Energy and Systems, Beijing Institute of Nanoenergy and Nanosystems, Chinese Academy of Sciences, Beijing, China.

ORCID profiles: Xi Liu, Cuiping Zhang

Funding

  • Natural Science Foundation of Beijing Municipality
  • National Key Research and Development Program of China
  • National Natural Science Foundation of China

Cite

APA

Tian, L., Wang, Z., Chen, S., Guo, K., Hao, Y., Ma, L., Ma, K., Chen, J., Liu, X., Li, L., Fu, X., & Zhang, C. (2025). Ellagic Acid‐Loaded sEVs Encapsulated in GelMA Hydrogel Accelerate Diabetic Wound Healing by Activating EGFR on Skin Repair Cells. Cell Proliferation, 58(10). https://doi.org/10.1111/cpr.70064

Vancouver

Tian L, Wang Z, Chen S, Guo K, Hao Y, Ma L, et al. Ellagic Acid‐Loaded sEVs Encapsulated in GelMA Hydrogel Accelerate Diabetic Wound Healing by Activating EGFR on Skin Repair Cells. Cell Proliferation. 2025;58(10). doi:10.1111/cpr.70064

BibTeX
@article{Tian2025,
  author = {Tian, Lige and Wang, Zihao and Chen, Shengqiu and Guo, Kailu and Hao, Yaying and Ma, Liqian and Ma, Kui and Chen, Junli and Liu, Xi and Li, Linlin and Fu, Xiaobing and Zhang, Cuiping},
  title = {Ellagic Acid‐Loaded sEVs Encapsulated in GelMA Hydrogel Accelerate Diabetic Wound Healing by Activating EGFR on Skin Repair Cells},
  journal = {Cell Proliferation},
  year = {2025},
  volume = {58},
  number = {10},
  doi = {10.1111/cpr.70064}
}
Start for free →